Progressive multifocal leukoencephalopathy (PML) may be a rare, myelin-damaging malady of the central system (CNS) in an exceedingly setting of immunological disorder that's superimposed by coinciding reaction diseases like induration and AIDS or synchronic administration of immune modulatory antibody medication like natalizumab. The motive agent may be a Polyomavirus referred to as John professional dancer (JC) virus (JCV) that affects oligodendrocytes and astrocytes leading to focal, intensive and progressive degenerative disorder across the brain. The pathological process of JCV latent and active infection is nevertheless to be totally understood despite important medical analysis. To date, no therapeutic intervention has been terribly effective in addressing the health implications of PML. during this article, we have a tendency to review the present data on the life cycle of JCV, pathological process of PML, highlight necessary tools within the designation, potential targets for management and therapeutic intervention of PML.
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Letter to Editor: Immunochemistry & Immunopathology
Letter to Editor: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Research Article: Immunochemistry & Immunopathology
Scientific Tracks Abstracts: Medical Microbiology & Diagnosis
Scientific Tracks Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Posters & Accepted Abstracts: Medical Microbiology & Diagnosis
Scientific Tracks Abstracts: Medical Microbiology & Diagnosis
Scientific Tracks Abstracts: Medical Microbiology & Diagnosis
Immunochemistry & Immunopathology received 174 citations as per Google Scholar report